Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-09

Clinical Trial Update: LUMENS-1 Canada Early Feasibility Study Clinical Investigation Plan [NA]

View source ↗

Summary

Canada-based LUMENS-1 early feasibility study clinical investigation plan by LuSeed Vascular LTD for cerebral aneurysm indications, with recruitment not yet sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMENS-1

Snippet

Sponsor: LuSeed Vascular LTD. | Conditions: Aneurysm Cerebral, Bifurcation | NA | Status: NOT_YET_RECRUITING